Are you above the legal age to view this content in your province/state?

Home / Cannabis Stock Market / Aphria becomes Tilray on Wednesday in giant pot merger

Aphria becomes Tilray on Wednesday in giant pot merger

This story originally appeared on Windsor Star.

Aphria becomes Tilray on Wednesday in giant pot merger

Leamington’s biggest private employer loses its name on Wednesday but will remain the controlling power behind a blockbuster merger of two Canadian pot giants in what becomes the world’s largest cannabis company.

Tilray Inc. shareholders on Friday followed suit with those of Aphria Inc. weeks earlier and voted to approve the merger which includes adopting Tilray as the shared name for the business combination. Tilray, headquartered in Nanaimo, B.C., will continue to be listed on the American Nasdaq exchange but will also commence trading on the Toronto Stock Exchange on May 5.

The two companies had a combined market value of over $10 billion at the afternoon close of stock market trading on Friday. Aphria chairman and CEO Irwin Simon takes the helm of the new company which bills itself as “a consumer packaged goods powerhouse” set to usher in “a new era in the global cannabis industry.”

Poised to “transform the industry” — workers are shown on Aug. 1, 2019, inside one of the Leamington operations of Aphria Inc., which now gets a new name, Tilray, following its merger with that fellow Canadian cannabis grower. PHOTO BY DAX MELMER /Windsor Star

Industry observers earlier billed the merger as being complementary from a business perspective and a positive development for Aphria’s holdings in Leamington, where the new company will retain a “principal office” at a location that employs about 700 workers at two large greenhouse cultivation operations, Aphria 1 and Aphria Diamond.

The merger, which the company says will deliver about $100 million in annual pre-tax operational savings within 18 months, comes two and a half years after Canada legalized recreational pot for adults and just seven years after a couple of Leamington greenhouse growers joined forces and began growing Essex County’s first commercial crop of medical marijuana.

The new company has holdings around the world and a growing portfolio of brands across cannabis-lifestyle and wellness product categories, including medical and adult recreational, hemp foods and beverages.

As markets in locations like Canada and Germany begin to reopen from COVID-19 lockdowns, Simon said in a company news release Monday that the new Tilray “is poised to strike and transform the industry.”


Disclaimer

Investment Value Finders specializes in providing opinions and information on stocks to individuals who wish to receive them. Our reports are construed for information purposes solely and are distributed free of charge to individuals who wish to receive them.


Investment Value Finders does not promote, condone or advocate licit or illicit drug use. Investment Value Finders cannot be held responsible for materials or contests posted on its website pages, or pages to which we provide links, which promote, condone or advocate licit or illicit drug use or illegal activities.


DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE. We are not registered as a securities broker-dealer or an investment adviser. We are neither licensed nor qualified to provide investment advice.


Investment Value Finders occasionally receives direct compensation for hosting links (or other* advertisements) to third party content that may be subject to disclaimer pursuant to Section 17(b) of the Securities Act of 1933. For those instances where the link text contains company or stock-specific mention, we provide the following list of compensation received in order to ensure full disclosure and transparency.


Investment Value Finders is intended for those 21+ years of age only!

Check Also

FSD Pharma Announces Closing of Lucid Psycheceuticals Acquisition

FSD Pharma Announces Closing of Lucid Psycheceuticals Acquisition

Lucid Adds Potential for Neurodegenerative Disease Treatments and Mental Health in a Novel Way TORONTO–(BUSINESS …